Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01611584

A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to measure ALA-induced fluorescence in both normal and malignant tissue.

Conditions

Interventions

TypeNameDescription
DRUGALA-induced FluorescenceALA Dose- 20 mg/kg

Timeline

Start date
2010-06-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2012-06-05
Last updated
2014-11-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01611584. Inclusion in this directory is not an endorsement.

A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lu (NCT01611584) · Clinical Trials Directory